Bispecific monoclonal antibodies, thrombolytic agent and method of cell lysis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 5, 1996
Issued Date -
N/A
app pub date -
Dec 6, 1994
filing date -
Apr 2, 1990
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed are a bispecific hybrid MoAb having specificity for both an activated platelet and a substance having thrombolytic activity, and a thrombolytic agent comprising the above bispecific MoAb and a substance having thrombolytic activity immunologically bound thereto, whereby efficient, rapid thrombolysis is possible.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully